Browse > Article

Association of the CYP1B1 Gene Polymorphism with the Risk of Advanced Endometriosis in Korean Women  

Cho, Yeon Jean (Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine)
Hur, Sung-Eun (Department of Obstetrics and Gynecology, College of Medicine, Konyang University)
Lee, Ji Young (Department of Obstetrics and Gynecology, College of Medicine, Konkuk University)
Song, In Ok (Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine)
Koong, Mi Kyoung (Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine)
Moon, Hye Sung (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University)
Chung, Hye-Won (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.33, no.2, 2006 , pp. 85-95 More about this Journal
Abstract
Objective: To investigate whether polymorphisms of gene encoding CYP1B1 is associated with the risk of endometriosis in Korean women. Methods: We investigated 199 patients with histopathologically confirmed endometriosis rAFS stage III/IV and 183 control group women who were surgically proven to have no endometriosis. The genetic distribution of four different CYP1B1 polymorphisms at $G^{119}-T$, $G^{432}-C$, $T^{449}-C$, and $A^{453}-G$ were analyzed by polymerase chain reaction(PCR) and restriction fragment length polymorphism of PCR products. Results: We found no overall association between each individual CYP1B1 genotype and the risk of endometriosis. The odds ratio of genotype GG/GC+GG/TC+TT/AA compared to GG/CC/CC/AA(reference) was calculated as 2.06 with a 95% confidence interval of 1.003~4.216. Conclusion: This results suggest that CYP1B1 genetic polymorphism may be associated with development of endometriosis in Korean women.
Keywords
Endometriosis; CYP1B1; Genetic polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kennedy SH. Is there a genetic basis to endometriosis? Semin Reprod Endocrinol 1997; 15: 309-17   DOI
2 Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkey (Macaca mulatto) following chronic exposure to 2,3,7,8tetrachlorodibeno-p-dioxin. Fudam Appl Toxicol 1993; 21: 433-41   DOI   ScienceOn
3 Bejjani BA, Lewis RA, Tomey KF, Anderson KL, Dueker DK, Jabak M, et al. Mutations in CYP1B1, the gene for cytochrome P450 1B1, are the dominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998; 62: 325-3   DOI   ScienceOn
4 Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Polymorphism of the CYP1B1 gene have higher risk for prostate cancer. Biochemical and Biophysical Research Communications 2002; 296: 820-6   DOI   ScienceOn
5 Zheng W, Xie D, Jin F, Cheong J, Dai Q, Wen W, et al. Genetic Polymorphism of cytochrome P450-1B1 and risk of Breast Cancer. Cancer Epidemiol Bio- markers Prev 2000; 9: 147-50
6 Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril. 2003; 79 Suppl 1: 702-9   DOI
7 American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil SteriI 1985;43: 351
8 Wieser F, Wenzl R, Tempfer C, Worda C, Huber J, Schneeberger C. Catechol-O-Methyltransferase polymorphism and endometriosis. J Assist Reprod Genet 2002; 19: 343-8   DOI   ScienceOn
9 Rylander-Rudqvist T, Werden S, Jonasdottir G, Ahlberg S, Werderpass E, Persson I, et al. Cytochrome P4501B1 gene polymorhpisms and postmenopausal endometriol cancer risk. Cancer Epidemiol Biornar-kers Prev 2004; 13: 1515-20
10 Rier SE, Foster WG. Environmental dioxins and endometriosis. Toxicol Sci 2002; 70: 161-70   DOI   ScienceOn
11 Wen W, Cai Q, Shu XO, Cheng JR, Pari R, Pierce L, et al. Cytochrome P450 1B1 and Catechol-OMethyltransferase genetic polymorphism and breast cancer risk in Chinese Women: Result from the Shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 329 -35   DOI   ScienceOn
12 Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assis Reprod Genet 1995; 12: 32-4   DOI   ScienceOn
13 Landi MT, Bergen AW, Baccarelli A, Patterson DG, Grassman J, Ter-Minassian M, et al. CYP1A1 and CYP181 genotypes, haplotypes and TCDD-induced gene expression in subjects from Seveso, Italy. Toxicol 2005; 207: 191-202   DOI   ScienceOn
14 Lemon HM, Heidel JR, Rodriguez-Sierra JF. Increased catecholestrogen metabolisms as a risk factor for nonfamilial breast cancer. Cancer Res 1992; 69: 457 -65
15 Lee KM, Abel J, Ko Y, Harth V, Park WY, Seo JS, et al. Genetic polymophisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean Women. British J of Can 2003; 88: 675-8   DOI   ScienceOn
16 Mammen JS, Pittman GS, Ying L, Abou-Shar F, Bejjani BA, Bell DA, et al. Single amino acid mutations, but not common polymorhpisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7Rtrasn-7,8-dihydrodiol. Carcinogensis 2003; 24: 1247 -55   DOI   ScienceOn
17 Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y, et al. Association of CYP 1B1 genetic polymorphisms with incidence to breast and lung cancer. Pharmacogenetics 2000; 10: 25-33   DOI   ScienceOn
18 Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillan EM, et al. Catalytic properties of polymorphic human cytochrome p-450 1B1 variants. Carcinogenesis 1999; 20: 1607-13   DOI   ScienceOn
19 Bailey LR, Roodi N, Dupont WD, Pari FF. Association of cytochrome p450 1B1(CYPlBI) polymorphisms with steroid receptor status in breast cancer. Cancer Res 1998; 58: 5038-41
20 Mayani A, Barel S, Soback S, Almagor M. Dioxin concentration in women with endometriosis. Hum Reprod 1997; 12: 373-5   DOI   ScienceOn
21 De Vivo I, Hankinson SE, Li L, Colditx GA, Hunter DJ. Association of CYP1B1 Polymorphism and Breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 489-92
22 Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis.: Failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998; 83: 4474-80   DOI
23 Zondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr Opin Obstet Gynecol 2001; 13: 309-14   DOI   ScienceOn
24 Bergqvist A, Ferno M. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Human Reprod 1993; 8: 2211-7   DOI
25 Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP. Activation of chemically diverse procarcinogens by human cytochrome 1B1. Cancer Res 1996; 56: 2979-84
26 Koninckx PR, Braet P, Kennedy SH, Barlow D. Dioxin population and endometriosis in Belgium. Hum Reprod 1994; 9: 1001-2   DOI
27 Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of $17\beta- estradiol$and estrone fromed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinolgy 2003; 144: 3382-98   DOI   ScienceOn
28 Rylander-Rudqvist T, Werden S, Granath R, Hum-phreys K, Ahlberg S, Weiderpass E, et al. Cytochrome P4501B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogensis 2003; 24: 1533-9   DOI   ScienceOn
29 Prentice A, Randall BJ, Weddell A, Mcgill A, Henry L, Home CH, et al. Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and mesothelium. Human Reprod 1992; 7: 1318-25   DOI
30 Moen MH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand 1993; 72: 560-4   DOI   ScienceOn
31 Nutter LM, Wu YY, Ngo EO, Sierra EE, Gutierrez PL, Abul-Hajj YJ. An o-quinone form of estrogen produced free radicals in human breast cancer cells: correlation with DNA damage. Chem Res Toxicol 1994; 7: 23-8   DOI   ScienceOn
32 McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I. Cytochrome P4501B1 and catechol-O-methyltransferase polymorphism and endometrial cancer susceptibility. Carcinogenesis 2004; 25: 559-65   DOI   ScienceOn
33 Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 1996; 92: 9220-4
34 Stoilov I, Akarsu AN, Alozie I, Child A, BarsoumHomsy M, Turachi ME, et al. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutation disrupting either the hinge region or the conserved core structure from cytochrome P4501B1. Am J Hum Genet 1998; 62: 573-84   DOI   ScienceOn
35 Tsuchiya Y, Nakajima M, Yokoi T. Critical enhancer region to which AhR/ARNT and Spl bind in the human CYP1B1 gene. J Biochem 2003:133:583-92   DOI   ScienceOn
36 Bulun SE, Zeitoun KM, Takayama K, Sasano H. Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance. J Mol Endocrinol 2000; 25: 35-42   DOI   ScienceOn
37 Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, et al, Isolation and characterization of the human cytochrome p450 CYPIBl gene. J. Biol Chem 1996; 271: 28324-30   DOI   ScienceOn
38 Hanna IH, Dawling S, Roodi N, Guengerich FP, Pari FF, Cytochrome P450181 (CYP181) pharmocogenetics: Association of polymorhpisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000; 60: 3440-4